Literature DB >> 12461745

Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.

Jane Bayani1, Maria Zielenska, Ajay Pandita, Khaldoun Al-Romaih, Jana Karaskova, Karen Harrison, Julia A Bridge, Poul Sorensen, Paul Thorner, Jeremy A Squire.   

Abstract

Conventional cytogenetic studies have shown that osteosarcomas (OSs) are often highly aneuploid, with a large number of both structural and numerical chromosomal alterations. To investigate the complexity of OS karyotypes in detail, we applied spectral karyotyping (SKY) to a series of 14 primary OS tumors and four established OS cell lines. A total of 531 rearrangements were identified by SKY, of which 300 breakpoints could be assigned to a specific chromosome band. There was an average of 38.5 breakpoints identified by SKY per primary tumor. Chromosome 20 was involved in a disproportionately high number of structural rearrangements, with 38 different aberrations being detected. Chromosomal rearrangements between chromosomes 20 and 8 were evident in four tumors. FISH analysis using a 20q13 subtelomeric probe identified frequent involvement of 20q in complex structural rearrangements of OS cell lines. Characterization of the structural aberrations of chromosomes 8 and 17 by use of SKY demonstrated frequent duplication or partial gains of chromosome bands 8q23-24 and 17p11-13. Other chromosomes frequently involved in structural alteration were chromosomes 1 (47 rearrangements) and 6 (38 rearrangements). Centromeric rearrangements often involving chromosomes 1, 6, 13, 14, 17, and 20 were present. Four of the 14 primary OS tumors were characterized by nonclonal changes that included both structural and numerical alterations. In summary, OS tumors have a very high frequency of structural and numerical alterations, compounded by gross changes in ploidy. This intrinsic karyotype instability leads to a diversity of rearrangements and the acquisition of composite chromosomal rearrangements, with the highest frequency of alteration leading to gain of 8q23-24 and 17p11-13 and rearrangement of 20q. These findings suggest that specific sequences mapping to these chromosomal regions will likely have a role in the development and progression of OS. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12461745     DOI: 10.1002/gcc.10132

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  35 in total

1.  The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma.

Authors:  Shamini Selvarajah; Maisa Yoshimoto; Paul C Park; Georges Maire; Jana Paderova; Jane Bayani; Gloria Lim; Khaldoun Al-Romaih; Jeremy A Squire; Maria Zielenska
Journal:  Chromosoma       Date:  2006-08-09       Impact factor: 4.316

2.  Genome-Informed Targeted Therapy for Osteosarcoma.

Authors:  Leanne C Sayles; Marcus R Breese; Amanda L Koehne; Stanley G Leung; Alex G Lee; Heng-Yi Liu; Aviv Spillinger; Avanthi T Shah; Bogdan Tanasa; Krystal Straessler; Florette K Hazard; Sheri L Spunt; Neyssa Marina; Grace E Kim; Soo-Jin Cho; Raffi S Avedian; David G Mohler; Mi-Ok Kim; Steven G DuBois; Douglas S Hawkins; E Alejandro Sweet-Cordero
Journal:  Cancer Discov       Date:  2018-09-28       Impact factor: 39.397

Review 3.  Soft tissue sarcomas with complex genomic profiles.

Authors:  Louis Guillou; Alain Aurias
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

4.  Induction of p21CIP1 protein and cell cycle arrest after inhibition of Aurora B kinase is attributed to aneuploidy and reactive oxygen species.

Authors:  Geeta Kumari; Tanja Ulrich; Michael Krause; Florian Finkernagel; Stefan Gaubatz
Journal:  J Biol Chem       Date:  2014-04-29       Impact factor: 5.157

5.  Predictive properties of DNA methylation patterns in primary tumor samples for osteosarcoma relapse status.

Authors:  Jeremy M Rosenblum; N Ari Wijetunga; Melissa J Fazzari; Mark Krailo; Donald A Barkauskas; Richard Gorlick; John M Greally
Journal:  Epigenetics       Date:  2015-01-23       Impact factor: 4.528

6.  c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells.

Authors:  Amanda Guffei; Zelda Lichtensztejn; Amanda Gonçalves Dos Santos Silva; Sherif F Louis; Andrea Caporali; Sabine Mai
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

7.  Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.

Authors:  Jane Bayani; Jana Paderova; Joan Murphy; Barry Rosen; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  Fusion between cancer cells and myofibroblasts is involved in osteosarcoma.

Authors:  Ling Yu; Weichun Guo; Shenghao Zhao; Fuan Wang; Yong Xu
Journal:  Oncol Lett       Date:  2011-07-14       Impact factor: 2.967

9.  Decitabine-induced demethylation of 5' CpG island in GADD45A leads to apoptosis in osteosarcoma cells.

Authors:  Khaldoun Al-Romaih; Bekim Sadikovic; Maisa Yoshimoto; Yuzhuo Wang; Maria Zielenska; Jeremy A Squire
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

Review 10.  Using Liquid Biopsy in the Treatment of Patient with OS.

Authors:  David S Shulman; Brian D Crompton
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.